Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2011-08-02
2011-08-02
Bockelman, Mark W (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S014000
Reexamination Certificate
active
07991469
ABSTRACT:
A device and method are presented for prolonging the atrial effective refractory period with pacing therapy. Such refractory period prolongation renders the atrial tissue less susceptible to the onset of atrial fibrillation. A particularly useful application is during the period after application of electrical therapy to the atria to terminate an episode of atrial fibrillation.
REFERENCES:
patent: 4554922 (1985-11-01), Prystowsky et al.
patent: 5334221 (1994-08-01), Bardy
patent: 5344221 (1994-09-01), MacWilliam
patent: 5645569 (1997-07-01), Ayers
patent: 5676687 (1997-10-01), Ayers
patent: 5741311 (1998-04-01), Mc Venes et al.
patent: 6377852 (2002-04-01), Bornzin et al.
patent: 6701187 (2004-03-01), Bornzin et al.
patent: 7062318 (2006-06-01), Ben-Haim et al.
patent: 7203538 (2007-04-01), Schwartz et al.
patent: 2001/0018600 (2001-08-01), Plicchi et al.
patent: 0811399 (1997-12-01), None
patent: 1118352 (2001-07-01), None
patent: 2000-502931 (2000-03-01), None
patent: WO-97/25098 (1997-07-01), None
patent: WO-9727797 (1997-08-01), None
“U.S. Appl. No. 10/302,747, Non-Final Office Action mailed Jul. 6, 2006”, 4 pgs.
“U.S. Appl. No. 10/302,747, Notice of Allowance mailed Nov. 28, 2006”, 4 pgs.
“U.S. Appl. No. 10/302,747, Response filed Apr. 10, 2006 to Restriction Requirement mailed Mar. 8, 2006”, 7 pgs.
“U.S. Appl. No. 10/302,747, Response filed Nov. 6, 2006 to Non-Final Office Action mailed Jul. 6, 2006”, 9 pgs.
“U.S. Appl. No. 10/302,747, Restriction Requirement mailed Mar. 8, 2006”, 5 pgs.
“European Application Serial No. 03769000.5, Communication dated Mar. 9, 2006”, 2 pgs.
“European Application Serial No. 03769000.5, Response filed Jul. 10, 2006 to Communication dated Mar. 9, 2006”, 1 pg.
“International Application Serial No. PCT/US03/37155, International Search Report mailed May 6, 2004”, 5 pgs.
“Japanese Application Serial No. 2004-555514, Office Action mailed Aug. 31, 2009”, (w/ partial translation), 4 pgs.
“Japanese Application Serial No. 2004-555514, Response filed Nov. 24, 2009 to Office Action mailed Aug. 31, 2009”, (w/ English Translation of Amended Claims), 37 pgs.
“Japanese Application Serial No. 2004-555514, Office Action mailed on Feb. 8, 2010”, (partial English translation), 2 pgs.
Krum, David , et al., “Pacing to Prevent Atrial Fibrillaation: The Effect of High Frequency Atrial Burst Pacing Algorithms on Atrial EPR”,Oral Presentation presented at PACE, North American Society of Pacing and Electrophysiology, May 17-20, 2000, Washington Convention Center, Washington, D.C., USA, 10.
Krum, David , et al., “Pacing to Prevent Atrial Fibrillation: The Effect of High Frequency Atrial Burst Pacing Algorithms on Atrial ERP”,PACE, vol. 23, No. 4, Part II, Apr. 2000, 582.
Wijffels, Maurits C., et al., “Atrial Fibrillation Begets Atrial Fibrillation: A Study in Awake Chronically Instrumented Goats”,Circulation, vol. 92, No. 7, (Oct. 1, 1995),1954-1968.
Schwartz Mark
Sra Jasbir
Bockelman Mark W
Cardiac Pacemakers Inc.
Schwegman Lundberg & Woessner, P.A.
LandOfFree
Pacing therapy for extending atrial refractory period does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pacing therapy for extending atrial refractory period, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pacing therapy for extending atrial refractory period will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2795029